Figure 1
Pictogram of the “arriba-PSA”. It combines information from eight other pictograms included in the transactional DA based on 1000 men (1 circle = 1 man) in the age range of 55–69 years undergoing PSA based early detection of PCa during a period of ten years. It contains information about: dying of PCa within the next ten years; being diagnosed with PCa (risk of a clinically significant vs. not significant cancer) within the next ten years; having false-positive or false-negative PSA test results (risk of “unnecessary” prostate biopsies vs. “false reassurance”) referring to a period of four years only. 1Overdiagnosis16,17: diagnosis of PCa unlikely to harm the man during his life-time. PSA = prostate specific antigen.
